OSU-T315 as an Interesting Lead Molecule for Novel B Cell-Specific Therapeutics.

In conclusion, OSU-T315 displays potency as B cell modulator, probably through a mechanism of action independent of ILK, and might serve as lead drug molecule for the development of novel B cell-selective drugs. PMID: 30276218 [PubMed - in process] (Source: Journal of Immunology Research)

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2P9xB96